Avacta Group Plc (AVCTF)
OTCMKTS · Delayed Price · Currency is USD
0.7899
0.00 (0.00%)
At close: Feb 11, 2026
Avacta Group Market Cap
Avacta Group has a market cap or net worth of $355.09 million as of February 12, 2026. Its market cap has increased by 59.20% in one year.
Market Cap
355.09M
Enterprise Value
365.68M
Revenue
154.82K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.79
Market Cap Chart
Since September 29, 2006, Avacta Group's market cap has increased from 70.11M to 355.09M, an increase of 406.49%. That is a compound annual growth rate of 8.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 355.09M | 4.95% |
| Dec 31, 2025 | 338.35M | 47.73% |
| Dec 31, 2024 | 229.04M | -44.84% |
| Dec 29, 2023 | 415.23M | 15.51% |
| Dec 30, 2022 | 359.48M | -16.19% |
| Dec 31, 2021 | 428.94M | 10.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 399.44M |
| CytoDyn | 311.51M |
| Silence Therapeutics | 211.61M |
| Vaxart | 145.24M |
| HST Global | 139.70M |
| BioStem Technologies | 105.50M |
| Nuo Therapeutics | 76.77M |
| VitaSpring Biomedical | 51.78M |